ATP-LRG-1: Questionnaire Survey of the Advanced Training Program for Laparoscopic Radical Gastrectomy

Sponsor
Fujian Medical University (Other)
Overall Status
Completed
CT.gov ID
NCT05219539
Collaborator
(none)
1,355
1
1.3
1057.5

Study Details

Study Description

Brief Summary

This study aims to evaluate the outcomes of the advanced training program for laparoscopic radical gastrectomy (ATP-LRG). The research subjects are the trainees who participated in this training program.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Written informed consent is not required because of the observational and anonymous nature of this study. ATP-LRG is a national training program carried out by Fujian Medical University Union Hospital. Each training lasts about 1.5 days, which includes 1) detailed technique description; 2) prevention and solving of intraoperative complications; 3) live surgery performance; 4) theory and practice of clinical research; 5) comments on trainees' videos; and 6) questions, answers and discussions. In this study, 875 trainees who participated in ATP-LRG from January 2015 to October 2020 were interviewed using electronic questionnaires. Using a repeated-measures design to examine differences in outcomes before and after participating in the training. Questionnaire Star (Changsha Ranxing Information Technology Co., Ltd), a most widely used professional online questionnaire software platform in China, was used to design and create a link to the questionnaire. The questionnaire's link was sent to each trainee via WeChat (Tencent Holdings Limited), the most commonly used social networking software in China.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    1355 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Outcomes of the National Advanced Training Program for Laparoscopic Radical Gastrectomy: a Survey Based on Follow-up Questionnaire
    Actual Study Start Date :
    Nov 11, 2021
    Actual Primary Completion Date :
    Dec 2, 2021
    Actual Study Completion Date :
    Dec 20, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Change of general surgical skills score [One year after participating in ATP-LRG]

      Change of general surgical skills score = posttraining general surgical skills score - pretraining general surgical skills score. Scores were evaluated using questionares.

    Secondary Outcome Measures

    1. Changes of laparoscopic gastrectomy acceptance score [One year after participating in ATP-LRG]

      Changes of laparoscopic gastrectomy acceptance score = posttraining laparoscopic gastrectomy acceptance score - pretraining laparoscopic gastrectomy acceptance score. Scores were evaluated using questionares.

    2. Changes of clinical research possibilities score [One year after participating in ATP-LRG]

      Changes of clinical research possibilities score= posttraining clinical research possibilities score - pretraining clinical research possibilities score. Scores were evaluated using questionares.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Participated in ATP-LRG between January 2015 and October 2020

    • Have contact information

    Exclusion Criteria:
    • Repeated participation in ATP-LRG

    • Refuse to fill out the questionnaire

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Fujian Medical University Union Hospital Fuzhou Fujian China 350001

    Sponsors and Collaborators

    • Fujian Medical University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Chang-Ming Huang, Prof., Professor, Fujian Medical University
    ClinicalTrials.gov Identifier:
    NCT05219539
    Other Study ID Numbers:
    • ATP-LRG-1
    First Posted:
    Feb 2, 2022
    Last Update Posted:
    May 10, 2022
    Last Verified:
    May 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 10, 2022